246 related articles for article (PubMed ID: 26000313)
1. The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia.
Chen P; Wang M; Li D; Jia Y; He N; Li W; Ma D; Ji C
J Immunol Res; 2015; 2015():416123. PubMed ID: 26000313
[TBL] [Abstract][Full Text] [Related]
2. Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.
Wang M; Chen P; Jia Y; He N; Li D; Ji C; Ma D
Oncotarget; 2015 Jul; 6(20):17958-67. PubMed ID: 26255628
[TBL] [Abstract][Full Text] [Related]
3. The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.
Zhang W; Tian X; Mumtahana F; Jiao J; Zhang T; Croce KD; Ma D; Kong B; Cui B
BMC Cancer; 2015 Oct; 15():717. PubMed ID: 26474968
[TBL] [Abstract][Full Text] [Related]
4. Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia.
Yu S; Liu C; Zhang L; Shan B; Tian T; Hu Y; Shao L; Sun Y; Ji C; Ma D
Int J Mol Sci; 2014 Jan; 15(2):1927-45. PubMed ID: 24473142
[TBL] [Abstract][Full Text] [Related]
5. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia.
Tian T; Sun Y; Li M; He N; Yuan C; Yu S; Wang M; Ji C; Ma D
Clin Chim Acta; 2013 Nov; 426():108-13. PubMed ID: 24064425
[TBL] [Abstract][Full Text] [Related]
6. Increased AHR Transcripts Correlate With Pro-inflammatory T-Helper Lymphocytes Polarization in Both Metabolically Healthy Obesity and Type 2 Diabetic Patients.
Zhao RX; He Q; Sha S; Song J; Qin J; Liu P; Sun YJ; Sun L; Hou XG; Chen L
Front Immunol; 2020; 11():1644. PubMed ID: 32849564
[TBL] [Abstract][Full Text] [Related]
7. Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia.
Hu Y; Li H; Zhang L; Shan B; Xu X; Li H; Liu X; Xu S; Yu S; Ma D; Peng J; Hou M
Hum Immunol; 2012 Jun; 73(6):629-35. PubMed ID: 22537755
[TBL] [Abstract][Full Text] [Related]
8. The Profile of T Helper Subsets in Bone Marrow Microenvironment Is Distinct for Different Stages of Acute Myeloid Leukemia Patients and Chemotherapy Partly Ameliorates These Variations.
Tian T; Yu S; Liu L; Xue F; Yuan C; Wang M; Ji C; Ma D
PLoS One; 2015; 10(7):e0131761. PubMed ID: 26134277
[TBL] [Abstract][Full Text] [Related]
9. Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma.
Peng Z; Hu Y; Ren J; Yu N; Li Z; Xu Z
Int J Med Sci; 2021; 18(1):99-108. PubMed ID: 33390778
[TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease.
Piccinni MP; Lombardelli L; Logiodice F; Kullolli O; Maggi E; Barkley MS
Front Immunol; 2019; 10():642. PubMed ID: 31001262
[TBL] [Abstract][Full Text] [Related]
11. Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.
Shen E; Wang M; Xie H; Zou R; Lin Q; Lai L; Li F; Liang Z; Xu Y; Zhou M
BMC Immunol; 2016 Jun; 17(1):20. PubMed ID: 27338754
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
Luan L; Han S; Wang H; Liu X
Int Immunopharmacol; 2015 Dec; 29(2):278-284. PubMed ID: 26585971
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating T‑helper 22 cells in patients with dilated cardiomyopathy.
Kong Q; Li X; Wu W; Yang F; Liu Y; Lai W; Pan X; Gao M; Xue Y
Mol Med Rep; 2014 Jul; 10(1):359-64. PubMed ID: 24737285
[TBL] [Abstract][Full Text] [Related]
14. Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia.
Li Q; Zhang L; Yang M; Xia R; Xia L; Liu F
Scand J Immunol; 2014 Oct; 80(4):276-82. PubMed ID: 24909905
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Th22, Th17 and CD4
Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M
Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675
[TBL] [Abstract][Full Text] [Related]
16. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J
Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787
[TBL] [Abstract][Full Text] [Related]
17. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.
Shao LL; Zhang L; Hou Y; Yu S; Liu XG; Huang XY; Sun YX; Tian T; He N; Ma DX; Peng J; Hou M
PLoS One; 2012; 7(12):e51339. PubMed ID: 23236476
[TBL] [Abstract][Full Text] [Related]
18. A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease.
Peng D; Xu B; Wang Y; Guo H; Jiang Y
PLoS One; 2013; 8(7):e68446. PubMed ID: 23874630
[TBL] [Abstract][Full Text] [Related]
19. Decreased percentages of regulatory T cells are necessary to activate Th1-Th17-Th22 responses during acute rejection of the peripheral nerve xenotransplantation in mice.
Chai H; Yang L; Gao L; Guo Y; Li H; Fan X; Wu B; Xue S; Cai Y; Jiang X; Qin B; Zhang S; Ke Y
Transplantation; 2014 Oct; 98(7):729-37. PubMed ID: 25093516
[TBL] [Abstract][Full Text] [Related]
20. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
